OSE Immunotherapeutics Unveils 2026–2028 Strategic Plan With Four Opportunities for Value CreationCompletion of Tedopi’s phase 3 in Non-Small ...

The Micotec Mill incorporates a patented milling process designed to refine organic materials with controlled precision. The Company holds exclusive utilization rights to this technology, positioning ...

Tony Blair has been dropped from consideration for Donald Trump’s “board of peace” in Gaza, following objections from several ...

New Delhi: The initial public offering (IPO) of pharma firm Corona Remedies, received 62 per cent on the first day of the ...

The Federal Government has ordered ministries, departments, and agencies to carry over 70 per cent of their 2025 capital ...

Atossa Therapeutics, Inc. ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative therapies in areas of significant unmet need in breast cancer, today announced ...

Enterprise Penetration: According to a McKinsey November 2025 survey, 23% of organizations are currently scaling an agentic ...

The Financing was entirely subscribed for by an arm’s length third party, 1010770 B.C. Ltd. Use of proceeds will be directed to ramp-up operations at the Company’s Empower Environmental Solutions ...

States enforce different winter manure spreading rules from complete bans to slope-specific guidelines for water protection.

Over 1,000 industry leaders to converge in Bhubaneswar for Odisha Pharma Summit on December 16: Peethaambaran Kunnathoor, Chennai Tuesday, December 9, 2025, 08:00 Hrs [IST] The mu ...

A journey of relentless commitment, Komal Ganotra bridges grassroots activism and policy reform to safeguard children and ...

The initial public offering (IPO) of pharma firm Corona Remedies, received 62 per cent on the first day of the share sale on Monday. The three-day IPO recei ...